laitimes

The A-share Chinese medicine sector has continued to rise Continuously Under the superposition of multiple factors, the price of Chinese herbal medicines has continued to rise

author:National Business Daily

Per reporter: Guo Rongcun Per intern reporter: Chen Hao Per editor: Liang Xiao

Today (January 4), the first day of the opening of the market in 2022, the Wind Chinese Medicine Index rose by 2.71% again, of which Xinguang Pharmaceutical (300519, SZ), Tongrentang (600085, SH), Hansen Pharmaceutical (002412, SZ) and other Chinese medicine stocks have risen and stopped, and the heat of the Chinese medicine sector has not decreased. In the context of a sharp correction in the pharmaceutical sector in the second half of 2021, Wind data shows that the Chinese medicine index rose by nearly 30% against the trend in 2021, of which the Chinese medicine index rose by 18% in the last two months of 2021 alone.

Recently, the Daily Economic News reporter visited one of the largest Chinese herbal medicine trading markets in the country - Guangzhou Qingping Chinese Herbal Medicine Market. A number of stall bosses told reporters that since the epidemic in 2020, most of the Chinese herbal medicines have been rising in price, and the current rise in Chinese herbal medicines has basically peaked. The Chinese herbal medicine analysts interviewed said that the rise in Chinese herbal medicines should last until the first half of 2022.

Daily economic news

Read on